- Home
- KRRO vs TMCI Comparison
KRRO vs TMCI Comparison
Compare KRRO & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- TMCI
- Stock Information
- Founded
- KRRO 2014
- TMCI 2014
- Country
- KRRO United States
- TMCI United States
- Employees
- KRRO N/A
- TMCI N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KRRO Health Care
- TMCI Health Care
- Exchange
- KRRO Nasdaq
- TMCI Nasdaq
- Market Cap
- KRRO 490.1M
- TMCI 464.4M
- IPO Year
- KRRO 2019
- TMCI 2021
- Fundamental
- Price
- KRRO $43.67
- TMCI $6.96
- Analyst Decision
- KRRO Strong Buy
- TMCI Hold
- Analyst Count
- KRRO 7
- TMCI 7
- Target Price
- KRRO $133.83
- TMCI $7.90
- AVG Volume (30 Days)
- KRRO 132.1K
- TMCI 384.2K
- Earning Date
- KRRO 11-12-2024
- TMCI 11-05-2024
- Dividend Yield
- KRRO N/A
- TMCI N/A
- EPS Growth
- KRRO N/A
- TMCI N/A
- EPS
- KRRO N/A
- TMCI N/A
- Revenue
- KRRO N/A
- TMCI $202,861,000.00
- Revenue This Year
- KRRO N/A
- TMCI $13.15
- Revenue Next Year
- KRRO N/A
- TMCI $8.36
- P/E Ratio
- KRRO N/A
- TMCI N/A
- Revenue Growth
- KRRO N/A
- TMCI 16.14
- 52 Week Low
- KRRO $30.01
- TMCI $3.92
- 52 Week High
- KRRO $98.00
- TMCI $15.98
- Technical
- Relative Strength Index (RSI)
- KRRO 43.00
- TMCI 39.76
- Support Level
- KRRO $41.03
- TMCI $6.75
- Resistance Level
- KRRO $52.00
- TMCI $7.75
- Average True Range (ATR)
- KRRO 6.03
- TMCI 0.38
- MACD
- KRRO 0.03
- TMCI -0.21
- Stochastic Oscillator
- KRRO 42.36
- TMCI 10.34
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.